Search Results 621-630 of 18739 for alzheimers
... Alzheimer's disease based solely on biomarker evidence. Alzheimers Dement. 2025 Apr; 21 (4):e70068. View PubMed; Ghatamaneni S, Coleman C, Shin I, Bruinsma T ...
Lecanemab-irmb injection is used to treat Alzheimer's disease. This medicine is to be given only by or under the supervision of your doctor. This product is ...
This study is being done to learn more about normal memory and aging, mild memory and thinking problems, Alzheimer's disease and other forms of dementia.
The purpose of this study is to evaluate the effectiveness and safety of gantenerumab versus placebo in participants with early (prodromal to mild) Alzheimer's ...
“Alzheimer's disease is an epidemic affecting 35 million people worldwide,” says Dr. Ertekin-Taner. “It's going to escalate unless we can stop it or slow it ...
Ronald Peterson, neurologist and director of Mayo Clinic's Alzheimer's Disease Research Center, will join Dr. Steven DeKosky to present the keynote, "On the ...
... Alzheimer's Disease (AD) to inform and select the best blood, CSF, urine, and other analyses to conduct in banked samples from a larger Phase 2b clinical trial.
ROCHESTER, Minn. — Elderly patients who receive anesthesia are no more likely to develop long-term dementia or Alzheimer's disease than other seniors, ...
Research shows as many as 1 in 5 people age 65 and older will develop mild cognitive impairment. Many of those will progress to Alzheimer's disease. But the new ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.